Close
Chris Yook represents clients in investigations and enforcement actions pursued by antitrust enforcement agencies and in complex litigation, including some of the largest class actions in the U.S. He also regularly advises companies on the antitrust implications of strategic business decisions. Chris is known for his work and thought leadership on technology regulation as well as on topics at the intersection of the antitrust and intellectual property laws.
Chris is recommended in the Legal 500 US guide and he has been consistently recognized in other publications as a "Rising Star" and "One to Watch" for antitrust litigation. He currently serves in a leadership position in the ABA Section of Antitrust Law as Co-Chair of the Technology Administrative Committee. Chris also sits on the executive board of the Asian Pacific American Bar Association of Maryland and is an American Bar Foundation Fellow.
Publications
- Contributor, Antitrust Law Developments (8th ed.)
- Contributor, 2018 Annual Review of Antitrust Law Developments
- Contributor, 2017 Annual Review of Antitrust Law Developments
- Perils of the Perilous-Leading Theory and Output Decisions, Antitrust Magazine, Vol. 33 No. 3 (2019)
- A Call for Greater Consistency in the Failing Firm Defense, 17-3 ABA Antitrust Source 3 (2017)
- Antitrust Post-Mortem of the Health Insurance Merger Decisions, American Health Lawyers Association
- Avoiding Failure: Applying Decision Theory to the Eminent Domain Jurisprudence, 20 Fed. Cir. B.J. 443 (2011)
back
